Milestone Pharmaceuticals Inc
MIST
Get informed when a big investor buys or sells
+ FollowMarket Cap$95.34M
Close$
$0.17
85.1% downside
Current Fair Value
85.1% downsideOvervalued by 85.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $95.34 Million |
|---|---|
| Enterprise Value | $161.76 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.75 |
| Beta | 0.97 |
| Outstanding Shares | 130,286,033 |
Return
| Return on Equity | -201.83% |
|---|---|
| Return on Assets | -37.56% |
| Return on Invested Capital | -31.94% |
Valuation & Multiples
| P/E Ratio | -1.63 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 96.63 |
| Enterprise Value to EBIT | -2.93 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.85 |
| Debt to Equity | 3.82 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
$0.10
Average shareholder expectationRevenue Estimate
$37.54 M
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
$1.01 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 7.3085▲ 243.70% |
|---|---|
| Total Calls | 36,300▼ 79.19% |
| Total Puts | 265,300▼ 68.77% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 36.32%▲ 4.73% |
|---|---|
| Total Invested | $36.43M▼ 31.99% |
| Investors Holding | 90▲ 4.00% |
ESG Score
No data